Session 2: February 16, 2022 - 12:00 to 2:00 pm

February 16, 2022

SERIES DESCRIPTION

In this three-session online course, participants will learn about the new science on the influence of environmental chemicals on cancer. The sessions are aimed at clinicians and also will be informative for policy makers, cancer researchers, and members of the public. Clinicians will be better able to answer patient questions, and they will gain skills in engaging in population-level policy change and community-based public health initiatives.

SESSION 2 DESCRIPTION

Air pollution and cancer. The science linking air pollution to cancers is strong. Given that reducing exposure is often beyond the control of the individual, what are opportunities for addressing air pollution in public health, research and community settings, and what roles can clinicians play?  

Target Audience

This activity is intended for clinicians & care providers from across all medical specialties.

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Demonstrate how to participate in community-based research and influence public health policies on air pollution.
  2. Advise patients on utilizing environmental health resources for education and prevention.
  3. Apply skills to educate patients on relevance and impact of public environmental resources.

Additional Information

Provided by: 

Dana-Farber Cancer Institute, DF/HCC Center for Cancer Equity and Engagement, Silent Spring Institute, UMass Lowell/Lowell Center for Sustainable Production, Cancer Free Economy Network & Mass General Brigham

          

                         

     

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Nursing
  • 2.00 Participation
Course opens: 
11/08/2021
Course expires: 
04/01/2022
Event starts: 
02/16/2022 - 12:00pm EST
Event ends: 
02/16/2022 - 2:00pm EST
Cost:
$0.00

February 16, 2022 | 12:00 - 2:00 PM ET

Session 2: Air pollution and cancer. The science linking air pollution to cancers is strong. Given that reducing exposure is often beyond the control of the individual, what are opportunities for addressing air pollution in public health, research and community settings, and what roles can clinicians play?

Introduction: A systems approach for integrating environmental chemicals in cancer prevention.

  • Polly Hoppin, ScD - UMass Lowell/Lowell Center for Sustainable Production and Cancer Free Economy Network

Speakers:

  • David Christiani, MD, MS, MPH - Mass General Hospital and Harvard T.H. Chan School of Public Health 
    • What we know about air pollution and cancer: science and interventions to reduce exposures. 
  • Mary White, ScD - Centers for Disease Control and Prevention (CDC) Division of Cancer Prevention and Control
    • A comprehensive approach to cancer prevention and air pollution: tools and resources that public health can provide
  • Roseann Bongiovanni, MPH - Executive Director, Chelsea Green Roots
    • Disproportionately Impacted: Air Pollution and Health in Chelsea - Community-level strategies to reduce air pollution and how clinicians and researchers can help. 
  • Judy Ou, PhD, MPH - Huntsman Cancer Institute, University of Utah
    • Effect of air pollution on mortality and morbidity among young cancer survivors.

Panel: Panelists will offer their perspectives on the speakers’ presentations, followed by discussion.

  • Moderator: Polly Hoppin, ScD
  • Gwen Collman, PhD - Deputy Director, National Institute of Environmental Health Sciences
    • What are we learning from community-based participatory research, and what do we need to know to intervene on risk factors like air pollution?
  • Narjust Duma, MD - Thoracic oncologist and Associate Director of the Cancer Care Equity Program, Dana-Farber Cancer Institute
    • Understanding the bigger picture: How to be an advocate for your patient.
  • Ned Ketyer, MD, MD, FAAP - Pediatrician, Physicians for Social Responsibility
    • A pediatrician’s experience serving as both clinician and influential voice in community-level and policy debates.

See Session 1 Program
See Session 3 Program

 

Roseann Bongiovanni, MPH
GreenRoots, Inc.
Chelsea, MA

David Christiani, MD, MPH, MS
Director, Harvard Education and Research Center for Occupational Safety and Health
Physician, Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital
Boston, MA

Gwen Collman, PhD
National Institute of Environmental Health Science
Durham, NC

Narjust Duma, MD
Thoracic Oncologist and Associate Director of Cancer Care Equity Program, Dana-Farber Cancer Institute
Boston, MA

Polly Hoppin, ScD
Research Professor, University of Massachusetts/Lowell - Lowell Center for Sustainable Production
Lowell, MA

Ned Ketyer, MD, FAAP
Pediatrician, Physicians for Social Responsibility
Pittsburgh, PA

Judy Ou, PhD, MPH
University of Utah
Huntsman Cancer Institute
Salt Lake City, UT

Mary White, ScD
Centers for Disease Control & Prevention (CDC) - Division of Cancer Prevention & Control
Atlanta, GA

Mass General Brigham is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mass General Brigham designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Credit Designation Statement

2 Contact Hours of Nursing Continuing Professional Development (NCPD), will be awarded for attending each presentation in its entirety and completing an evaluation.

Approval Statement

Dana-Farber Cancer Institute is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Nursing
  • 2.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.